Posted by Michael Wonder on 16 Nov 2015
FDA approves Darzalex for patients with previously treated multiple myeloma
16 November 2015 - Today the U.S. FDA granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments.
For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472875.htm
